Breast Cancer Diagnostic and Drug Technologies Market Size, Status and Forecast

akshay dalvi

Breast Cancer Diagnostic and Drug Technologies Market Size, Status and Forecast

Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.

In 2018, the global Breast Cancer Diagnostic and Drug Technologies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019–2025.

Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-breast-cancer-diagnostic-drug-technologies-2019-2025-137

This report focuses on the global Breast Cancer Diagnostic and Drug Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Cancer Diagnostic and Drug Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Abbott
Roche
BioMerieux
Becton Dickinson
GE Healthcare
Hologic
Philips
PerkinElmer
Quest Diagnostics

Market segment by Type, the product can be split into

Mammography
Biopsy
Other

Market segment by Application, split into

Ductal Carcinoma of Breast
Invasive Ductal Carcinoma
Lobular Carcinoma
Triple Negative Breast Cancer

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Breast Cancer Diagnostic and Drug Technologies status, future forecast, growth opportunity, key market and key players.
To present the Breast Cancer Diagnostic and Drug Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Breast Cancer Diagnostic and Drug Technologies are as follows:

History Year: 2014–2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-breast-cancer-diagnostic-drug-technologies-2019-2025-137

Table of content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type (2014–2025)
1.4.2 Mammography
1.4.3 Biopsy
1.4.4 Other
1.5 Market by Application
1.5.1 Global Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2019–2025)
1.5.2 Ductal Carcinoma of Breast
1.5.3 Invasive Ductal Carcinoma
1.5.4 Lobular Carcinoma
1.5.5 Triple Negative Breast Cancer
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Breast Cancer Diagnostic and Drug Technologies Market Size
2.2 Breast Cancer Diagnostic and Drug Technologies Growth Trends by Regions
2.2.1 Breast Cancer Diagnostic and Drug Technologies Market Size by Regions (2019–2025)
2.2.2 Breast Cancer Diagnostic and Drug Technologies Market Share by Regions (2014–2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter?s Five Forces Analysis

3 Market Share by Key Players
3.1 Breast Cancer Diagnostic and Drug Technologies Market Size by by Players
3.1.1 Global Breast Cancer Diagnostic and Drug Technologies Revenue by by Players (2014–2019)
3.1.2 Global Breast Cancer Diagnostic and Drug Technol

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Email: [email protected]

akshay dalvi

Epigenetics Drugs And Diagnostics Market Growth Accelerated By Emerging Personalized Medicine Approach

kiran gire 2024-02-01

The global Epigenetics Drugs and Diagnostic Technologies Market is estimated to be valued at US$ 12. This helps in developing personalized drug therapies and predictive, preventive and personalized medicine approaches. Various companies are focusing on development of epigenetic diagnostic tools and drugs for precision medicine in disease areas like oncology. Segment Analysis The global Epigenetics Drugs and Diagnostic Technologies market is dominated by drugs and technologies sub segments. The drugs sub segment dominates the market currently due to increasing approvals and demand for targeted therapies in various cancer indications.

Lung Cancer Diagnostic And Screening Market Overview 2024-2033 – Competitive Landscape and Strategies

saikiran TBRC 2024-03-01

Learn More On The Lung Cancer Diagnostic And Screening Market:https://www. The lung cancer diagnostic and screening market size is expected to see strong growth in the next few years. The increasing prevalence of lung cancer is expected to propel the growth of the lung cancer diagnostic and screening market going forward. Therefore, the rise in the prevalence of lung cancer is driving the growth of the lung cancer diagnostic and screening market. The lung cancer diagnostic and screening market report table of contents includes:1.

Nanoparticle Based Screening Is Fastest Growing Segment Fueling The Growth Of Lung Cancer Diagnostic And Screening Market

Gauri Cmi 2023-12-12

Nanoparticles are being widely used to develop new approaches for lung cancer screening and diagnostics. Researchers are also exploring the use of nanoparticles as carriers for targeted drug delivery to lung cancer sites post-detection. Segment Analysis The global lung cancer diagnostic and screening market is segmented on the basis of type, product, end user and region. Based on type, the market is segmented into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Regional analysis Regionally, North America dominates the lung cancer diagnostic and screening market and is expected to continue its dominance over the forecast period.

The Global Lung Cancer Diagnostic And Screening Market Growing Adoption Of Digital Biomarkers To Diagnose And Screen Lung Cancer

Ashish Thapa 2023-12-28

The lung cancer diagnostic and screening market encompasses various tools and technologies that are used to detect lung cancer at an early stage. The global Lung Cancer Diagnostic And Screening Market is estimated to be valued at US$ 2243. The quantitative collection of digital biomarkers through smartphones and wearable devices expands access to lung cancer screening tests and improves patient outcomes. Segment Analysis The global Lung Cancer Diagnostic and Screening market is dominated by the cancer diagnostics segment. The global lung cancer diagnostic and screening market Market is estimated to be valued at US$ 2243.

Pancreatic Cancer Therapeutics and Diagnostic Market Growth, Business Opportunities, Share Value, Key Insights and Size estimation by 2030 | Myriad Genetics Inc., Pfizer Inc., Novartis AG

Alex Blaze 2023-04-11

The Pancreatic Cancer Therapeutics and Diagnostic Market is segmented -Key Players:Myriad Genetics Inc. North America was the largest region in the Pancreatic Cancer Therapeutics and Diagnostic Market. Have Any Questions Regarding Pancreatic Cancer Therapeutics and Diagnostic Market Report, Ask Our Experts @ https://www. ✤ The many strategy matrices used in researching the global Pancreatic Cancer Therapeutics and Diagnostic Market will aid stakeholders in making decisions. ◘ In-depth analysis of the Pancreatic Cancer Therapeutics and Diagnostic Market segmentation assists to determine the prevailing market opportunities.

Lung Cancer Diagnostic And Screening Procedures First Steps In Diagnosing Lung Cancer

Poonam 2024-03-14

Diagnostic Imaging TestsIf a patient experiences concerning lung cancer symptoms or is considered at high risk, their doctor will likely order imaging tests to examine the lungs more closely. - MRI (Magnetic Resonance Imaging) Scan - Used less commonly than CT scans for lung cancer, MRI uses magnetic fields and radio waves rather than radiation. Studies show CT screening can reduce lung cancer deaths. Biomarker blood tests and chest X-rays are not recommended for lung cancer screening due to inferior accuracy versus CT. Get more insights, On Lung Cancer Diagnostic and Screening

WHO TO FOLLOW

MORE FROM AUTHOR

Still Wine Sales Market Report by Manufacturer, Region, Type and Application

akshay dalvi 2019-10-22

Tinned Fruits Sales Market Report by Manufacturer, Region, Type and Application

akshay dalvi 2019-10-22

Water & Wastewater Treatment Technologies Market Insights

akshay dalvi 2019-10-22

Anatomic Pathology Laboratory Information System Market Professional Survey Report

akshay dalvi 2019-10-22

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Lung Cancer Diagnostic and Screening Market - Advancements and Growth Opportunities

Yashvi Gadhiya 2023-08-25

A) Market Overview: The global Lung Cancer Diagnostic and Screening Market is estimated to be valued at US$ 1,931. The market for lung cancer diagnostic and screening products has witnessed significant advancements in recent years, with the aim of improving accuracy, efficiency, and early detection of lung cancer. B) Market Key Trends: One key trend shaping the lung cancer diagnostic and screening market is the integration of artificial intelligence (AI) and machine learning (ML) techniques. D) Key Takeaways: - The global Lung Cancer Diagnostic and Screening Market is expected to witness high growth, exhibiting a CAGR of 7. In conclusion, the lung cancer diagnostic and screening market is poised for substantial growth due to increasing awareness, technological advancements, and the urgent need for early detection and accurate diagnosis.

Biomarkers Are Fastest Growing Segment Fueling The Growth Of Pancreatic Cancer Therapeutics And Diagnostic Market

Lucy Kart 2023-11-30

The global pancreatic cancer Therapeutics And Diagnostics Market is estimated to be valued at US$ 4255. With over 75 targeted drugs and 200 biomarker assays in the pipeline, their clinical application holds tremendous potential to transform pancreatic cancer management in the coming years. Segment Analysis The global pancreatic cancer therapeutics and diagnostic market is segmented based on therapeutic, diagnostic, end user and distribution channel. By diagnostic, imaging holds the largest share as imaging techniques aid in accurate diagnosis and staging of pancreatic cancer. Regional analysis- North America dominates the global pancreatic cancer therapeutics and diagnostic market due to robust healthcare infrastructure, presence of key pharmaceutical companies and availability of advanced treatment alternatives.

Drug Discovery Technologies Market Size, Key Players Analysis And Forecast To 2028 | Value Market Research

Anjali Aahuja 2022-07-04

The global Drug Discovery Technologies Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2022-2028. Get more information on "Global Drug Discovery Technologies Market Research Report" by requesting FREE Sample Copy at https://www. Browse Global Drug Discovery Technologies Market Research Report with detailed TOC at https://www. By Technology Type· High Throughput Screening· Genomics· Biochips· Pharmacogenomics· Bioanalytical Instruments· Bioinformatics· Nanotechnology· Others (RNAi, Combinatorial Chemistry)By End User· Pharmaceutical Companies· Biopharmaceutical Companies· Biotech Companies· Research InstitutesRegional AnalysisThis section covers the regional outlook, which accentuates current and future demand for the Drug Discovery Technologies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Purchase Complete Global Drug Discovery Technologies Market Research Report at https://www.

Cervical Cancer Drug Market Industry Analysis, Size, Share, Growth and Forecast To 2028

Data Bridge Market Research 2022-03-09

Increase in the cases of cervical cancer drug is the vital factor escalating the market growth. The Cervical Cancer Drug Market Scope and SizeAn influential Cervical Cancer Drug Market report is a total overview of the market that covers various aspects of product definition, market segmentation based on various parameters, and the existing vendor landscape. This market research report is a scrupulous analysis of current scenario of the market, which covers several market dynamics. dbmr=global-cervical-cancer-drug-marketThis Cervical Cancer Drug Market study also estimates the market status, market share, growth rate, sales volume, future trends, market drivers, market restraints, revenue generation, opportunities and challenges, risks and entry barriers, sales channels, and distributors. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, ALLERGAN, Pfizer Inc, AstraZeneca, Eli Lilly and Company, Novartis AG, Hetero, Alnylam Pharmaceuticals, Inc, among other domestic and global playersMAJOR TOC OF THE REPORTChapter One: Cervical Cancer Drug Machine Market OverviewChapter Two: Manufacturers ProfilesChapter Three: Cervical Cancer Drug Machine Market Competition, by PlayersChapter Four: Cervical Cancer Drug Machine Market Size by RegionsChapter Five: Cervical Cancer Drug Machine Market Revenue by CountriesChapter Six: Cervical Cancer Drug Machine Market Revenue by TypeChapter Seven: Cervical Cancer Drug Machine Market Revenue by ApplicationChapter Eight: Cervical Cancer Drug Machine Market Revenue by IndustriesChapter Nine: Cervical Cancer Drug Machine Market Revenue by Deployment ModelChapter Ten: Cervical Cancer Drug Machine Market Revenue by End UserGet TOC Details: https://www.

Immunotherapy is fastest growing segment fueling the growth of pancreatic cancer therapeutics and diagnostics market

Sumedha 2023-12-13

The pancreatic cancer therapeutics and diagnostic market is estimated to be valued at US$ 4255. According to the statistics provided by Pancreatic Cancer Action Network, pancreatic cancer is the third leading cause of cancer-related deaths in the United States. It is estimated that around 62,210 new cases of pancreatic cancer will be diagnosed and around 49,830 deaths will occur due to pancreatic cancer in the United States in 2022. Key Takeaways The Global Pancreatic Cancer Therapeutics and Diagnostic Market Size is expected to witness high growth, exhibiting CAGR of 7. Key players operating in the pancreatic cancer therapeutics and diagnostic market are F Hoffmann-La Roche AG, Merck KgaA, Apexigen Inc.

Cancer Diagnostic Devices Market Forecast and Analysis by 2028: BD, Abbott Diagnostics, Thermo Fisher Scientific and Others

Gift Panashe 2023-04-13

An in-depth analysis of Cancer Diagnostic Devices market dynamics, including market opportunities, major trends, and forecasts for the period 2023-2028, is also provided. This report provides an in-depth, focused analysis of Cancer Diagnostic Devices industry key market segments:By Types covered are:Companion diagnosticsMolecular diagnosticsBy Applications covered are:HospitalClinicOtherMajor Region Covered in the Cancer Diagnostic Devices industry report:The global Cancer Diagnostic Devices market analyzes its status and forecast. Gain insight into the current Cancer Diagnostic Devices market scenario in various countries. Analyze the current and future outlook of the Global Cancer Diagnostic Devices market in both developed and emerging markets. Review the former, ongoing, and projected analysis of the Cancer Diagnostic Devices market in terms of volume and value.

Drug Discovery TechnologiesMarket 2023-2032 Overview

jagadeeshwaritbrc 2023-11-17

The Drug Discovery Technologies Global Market Report 2023, provides comprehensive information on the drug discovery technologies market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The drug discovery technologies market is expected to reach $97. id=12715&type=smpThe invention of advanced technologies is a key trend in the drug discovery technologies market. Major companies operating in the drug discovery technologies market are launching advanced technologies to sustain their position in the market. The table of contents in TBRC’s drug discovery technologies market report includes:1.

Lung Cancer Diagnostic Tests Market Size, In-depth Analysis Report and Global Forecast to 2028

Anubha Singh 2022-06-28

COVID-19 Impact Analysis on Lung Cancer Diagnostic Tests Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2022-2028. Get more information on "Global Lung Cancer Diagnostic Tests Market Research Report" by requesting FREE Sample Copy at https://www. Browse Global Lung Cancer Diagnostic Tests Market Research Report with detailed TOC at https://www. By Type· Immunoassays· Flow Cytometry· Rapid Tests· Molecular Assays· Tissue Arrays· Circulating Tumor Cells· Pharmacodiagnostics· Biomarkers· OtherBy Application· Industrial· Healthcare· OtherRegional AnalysisThis section covers the regional outlook, which accentuates current and future demand for the Lung Cancer Diagnostic Tests market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Purchase Complete Global Lung Cancer Diagnostic Tests Market Research Report at https://www.

Epigenetics Drugs and Diagnostic Technologies Market 2020-2025| Comprehensive Study COVID19 Impact

shubham gosavi 2020-11-20

Epigenetics Drugs and Diagnostic Technologies Market is valued at USD 7.71 Billion in 2018 and expected to reach USD 27.13 Billion by 2025 with the CAGR of 19.68% over the forecast period.Growing prevalence of oncological and non-oncological conditions like respiratory diseases, alzheimer disease and growing R & D investments in the healthcare industries promotes the growth of global epigenetics drugs and diagnostic technologies market.

Epigenetic change is a normal and natural phenomenon but can also be affected by a variety of factors like age, environment or lifestyle and disease state.

New and ongoing work continues to uncover the role of epigenetics in a variety of human disorders and fatal diseases.

Epigenetic drugs and diagnostics are used in early stage cancer screening, as well as other pathological modifications in skin cells, liver cells, brain cells and others.

On the basis of country level, global Epigenetics Drugs and Diagnostic Technologies Market sub divided in U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.Epigenetics Drugs and Diagnostic Technologies CompaniesGlobal Epigenetics Drugs and Diagnostic Technologies Market reports cover prominent players,Zymo researchCellCentric LtdThermo Fisher ScientificAbcam, Eisai Co. LtdDiagenodeMerckElli LillySyndax Pharmaceuticals, Inc.QiagenChroma Therapeutics LtdNovartis International AGOncolys Biopharma IncSigma-Aldrich CorporationValirx Plcothers.

Cancer is a leading cause of death for children and adolescents worldwide and about 300,000 children aged 0 to 19 are diagnosed with cancer every year.

Liver Cancer Diagnostic Market 2022 New Opportunities, Dynamics With Financial Facts By 2028

Akshitha 2022-04-14

The key players in the liver cancer diagnostic market includes Abbott Laboratories, Agilent Technologies, Inc. Get more information on “Global Liver Cancer Diagnostic Market Research Report” by requesting FREE Sample Copy athttps://www. Browse Global Liver Cancer Diagnostic Market Research Report with detailed TOC athttps://www. com/report/liver-cancer-diagnostic-marketMarket SegmentationThe broad liver cancer diagnostic market has been sub-grouped into test type and end-user. Purchase complete Global Liver Cancer Diagnostic Market Research Report athttps://www.

Global Epigenetics Drugs and Diagnostic Technologies Market Size | US$45.9 Bn Expected Revenue by 2029, CAGR 19%, Key Players: Novartis AG, Illumina INC

krajput 2024-03-28

9 Billion by 2029Maximize Market Research unveils a comprehensive study on the Global Epigenetics Drugs and Diagnostic Technologies Market. Impact of COVID-19The report acknowledges the impact of the COVID-19 pandemic on the Global Epigenetics Drugs and Diagnostic Technologies Market. Availability of the ReportThis press release provides a brief overview of the Global Epigenetics Drugs and Diagnostic Technologies Market. The Maximize Market Research report offers a detailed analysis of the market, including market size and growth forecasts, market segmentation, competitive landscape insights, and Porter's Five Forces analysis. com/market-report/north-america-iot-in-smart-cities-market/9647/ Global Automatic Emergency Braking (AEB) Market https://www.

Europe Cancer Diagnostics Market: A Comprehensive Analysis of Cancer Diagnostics in Europe

maddyharshu 19h

The Europe cancer diagnostics market is driven by the rising prevalence of cancer, supporting initiatives for early cancer diagnosis, increasing investments and funding for cancer research, rising awareness about cancer, and advancements in cancer diagnostics technology. Furthermore, supporting initiatives toward precision diagnostics for cancer are expected to generate growth opportunities for the players operating in the Europe cancer diagnostics market. Based on cancer type, the Europe cancer diagnostics market is segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, and other cancer types. Governments and organizations are actively implementing breast cancer screenings, breast cancer awareness programs, and raising breast cancer funding to boost cancer research. For instance, In October 2023, Galderma SA (Switzerland) launched a new breast cancer campaign called ‘Facing Breast Cancer Together’, this campaign focuses on providing support and education about breast cancer awareness.

Epigenetics Drugs And Diagnostic Technologies Market Size, Share & Industry Forecast Research Report

Deniyal Berich 2023-06-27

The key players in the epigenetics drugs and diagnostic technologies market include 4SC AG, Acetylon Pharmaceuticals, Inc. Get more information on "Global Epigenetics Drugs And Diagnostic Technologies Market Research Report" by requesting FREE Sample Copy at https://www. Browse Global Epigenetics Drugs And Diagnostic Technologies Market Research Report with detailed TOC at https://www. com/report/epigenetics-drugs-and-diagnostic-technologies-marketMarket SegmentationThe broad epigenetics drugs and diagnostic technologies market has been sub-grouped into drugs mechanism of action and technology type. Purchase complete Global Epigenetics Drugs And Diagnostic Technologies Market Research Report at https://www.

Liver Cancer Diagnostic Market Analysis, Trends, Rising Growth, New Project Investment And Forecast 2025

Joseph Scott 2021-06-01

The global Liver Cancer Diagnostic Market scope was projected at US$ 8.25 billion in 2017.

Liver cancer diagnostic refers to advanced medical techniques used in healthcare facilities to confirm presence of unwanted cell growth in human body.

Available laboratory tests for HCC include urinalysis, sputum cytology, immunophenotyping, and urine cytology.

For instance, in September 2019, Laboratory for Advanced Medicine (LAM) has received breakthrough device designation from food and drug administration (FDA).

Such tests include magnetic resonance imaging (MRI), computed tomography (CT) scan, ultrasound, x-ray, and other radiographic tests.End-User Insights:In terms of end-user, the liver cancer diagnostics market is classified into independent laboratories, hospital associated labs, cancer research institutes, and others.

This is attributed to continuous research on development of effective therapeutic methods aimed to reduce mortality rate across the globe.Regional Insights:Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East and Africa.

Lung Cancer Diagnostic and Screening Market - Advancements and Growth Opportunities

Yashvi Gadhiya 2023-08-25

Epigenetics Drugs and Diagnostic Technologies Market 2020-2025| Comprehensive Study COVID19 Impact

shubham gosavi 2020-11-20

Epigenetic change is a normal and natural phenomenon but can also be affected by a variety of factors like age, environment or lifestyle and disease state.

New and ongoing work continues to uncover the role of epigenetics in a variety of human disorders and fatal diseases.

Epigenetic drugs and diagnostics are used in early stage cancer screening, as well as other pathological modifications in skin cells, liver cells, brain cells and others.

Cancer is a leading cause of death for children and adolescents worldwide and about 300,000 children aged 0 to 19 are diagnosed with cancer every year.

Biomarkers Are Fastest Growing Segment Fueling The Growth Of Pancreatic Cancer Therapeutics And Diagnostic Market

Lucy Kart 2023-11-30

Liver Cancer Diagnostic Market 2022 New Opportunities, Dynamics With Financial Facts By 2028

Akshitha 2022-04-14

Drug Discovery Technologies Market Size, Key Players Analysis And Forecast To 2028 | Value Market Research

Anjali Aahuja 2022-07-04

Global Epigenetics Drugs and Diagnostic Technologies Market Size | US$45.9 Bn Expected Revenue by 2029, CAGR 19%, Key Players: Novartis AG, Illumina INC

krajput 2024-03-28

Cervical Cancer Drug Market Industry Analysis, Size, Share, Growth and Forecast To 2028

Data Bridge Market Research 2022-03-09

Immunotherapy is fastest growing segment fueling the growth of pancreatic cancer therapeutics and diagnostics market

Sumedha 2023-12-13

Europe Cancer Diagnostics Market: A Comprehensive Analysis of Cancer Diagnostics in Europe

maddyharshu 19h

Cancer Diagnostic Devices Market Forecast and Analysis by 2028: BD, Abbott Diagnostics, Thermo Fisher Scientific and Others

Gift Panashe 2023-04-13

Epigenetics Drugs And Diagnostic Technologies Market Size, Share & Industry Forecast Research Report

Deniyal Berich 2023-06-27

Drug Discovery TechnologiesMarket 2023-2032 Overview

jagadeeshwaritbrc 2023-11-17

Liver Cancer Diagnostic Market Analysis, Trends, Rising Growth, New Project Investment And Forecast 2025

Joseph Scott 2021-06-01

The global Liver Cancer Diagnostic Market scope was projected at US$ 8.25 billion in 2017.

Liver cancer diagnostic refers to advanced medical techniques used in healthcare facilities to confirm presence of unwanted cell growth in human body.

Available laboratory tests for HCC include urinalysis, sputum cytology, immunophenotyping, and urine cytology.

For instance, in September 2019, Laboratory for Advanced Medicine (LAM) has received breakthrough device designation from food and drug administration (FDA).

Lung Cancer Diagnostic Tests Market Size, In-depth Analysis Report and Global Forecast to 2028

Anubha Singh 2022-06-28